Skip to main content
Clinical Trials/NCT04778969
NCT04778969
Unknown
Not Applicable

Coronary Artery Disease Patients Treated With Percutaneous Coronary Intervention: Analysis of the Korean Nationwide Health Insurance Database

Seoul National University Hospital0 sites200,000 target enrollmentApril 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Seoul National University Hospital
Enrollment
200000
Primary Endpoint
All cause of death
Last Updated
5 years ago

Overview

Brief Summary

Current Status and Prognosis of Coronary artery disease patients treated with coronary intervention - Analysis of the Korean Nationwide Health Insurance Database

Detailed Description

This is a retrospective study and is conducted for all patients who received percutaneous coronary intervention among cohorts registered with the National Health Insurance Service. Primary outcome is all cause of mortality. Secondary outcomes are cardiovascular death, ischemic stroke, cerebral hemorrhage, admission due to gastrointestinal bleeding, and admission due to major bleedings.

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
April 1, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Han-Mo Yang

Professor

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • All coronary artery disease patients wih Korean NHIS (National Health Insurance Service)-listed PCI

Exclusion Criteria

  • non-specified

Outcomes

Primary Outcomes

All cause of death

Time Frame: 10 years

'All cause of death' will be recorded as number of participants with 'All cause of death'

Secondary Outcomes

  • Admission due to gastrointestinal bleeding(10 years)
  • Cerebral hemorrhage(10 years)
  • Cardiovascular death(10 years)
  • Admission due to major bleeding(10 years)
  • ischemic stroke(10 years)

Similar Trials